67 related articles for article (PubMed ID: 26946938)
1. Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data.
Freeman K; Taylor-Phillips S; Willis BH; Ryan R; Clarke A
BMJ Open; 2021 Feb; 11(2):e044177. PubMed ID: 33619196
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic.
Jere M; Garrick V; Curtis L; Tayler R; Gervais L; Gerasimidis K; Hansen R
BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 33947712
[TBL] [Abstract][Full Text] [Related]
3. Home-based fecal calprotectin utilization in a general pediatric gastroenterology clinic.
Schmidt ML; McCrady E; Lee A; Bowerbank T; Miller MR; Watson M; Dhandapani A; Woolfson JP; Zizzo AN; Bax K; Crowley E
J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):790-799. PubMed ID: 38318970
[TBL] [Abstract][Full Text] [Related]
4. Faecal calprotectin for differentiating between irritable bowel syndrome and inflammatory bowel disease: a useful screen in daily gastroenterology practice.
Banerjee A; Srinivas M; Eyre R; Ellis R; Waugh N; Bardhan KD; Basumani P
Frontline Gastroenterol; 2015 Jan; 6(1):20-26. PubMed ID: 28839790
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Diagnostic Spectrum of Children with Raised Faecal Calprotectin Levels.
Vernon-Roberts A; Humphrey O; Day AS
Children (Basel); 2024 Apr; 11(4):. PubMed ID: 38671637
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of and Practices for the Management of Constipation: Results of a Korean National Survey.
Cho YS; Park SY; Shin JE; Park KS; Kim JW; Lee TH; Kim SE; Lee YJ; Ryu HS;
Gut Liver; 2024 Mar; 18(2):275-282. PubMed ID: 37458067
[TBL] [Abstract][Full Text] [Related]
7. Perceived value of computed tomography imaging for patients with inflammatory bowel disease in the emergency department: a Canadian survey.
Roda CAN; Dube C; Macdonald BD; Stiell IG; Moloo H; deBuck van Overstraeten A; Murthy S; Mallick R; McCurdy JD
J Can Assoc Gastroenterol; 2024 Jun; 7(3):261-268. PubMed ID: 38841143
[TBL] [Abstract][Full Text] [Related]
8. Sexual health in adolescents with inflammatory bowel disease - The paediatric gastroenterologists' point of view.
Anafy A; Cohen S; Matar M; Shouval DS; Shamir R; Weintraub Y
Acta Paediatr; 2024 Jun; ():. PubMed ID: 38850099
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of fecal calprotectin.
Ricciuto A; Griffiths AM
Crit Rev Clin Lab Sci; 2019 Aug; 56(5):307-320. PubMed ID: 31088326
[TBL] [Abstract][Full Text] [Related]
11. Faecal Calprotectin.
Pathirana WGW; Chubb SP; Gillett MJ; Vasikaran SD
Clin Biochem Rev; 2018 Aug; 39(3):77-90. PubMed ID: 30828114
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases.
Kan YM; Chu SY; Loo CK
JGH Open; 2021 Jun; 5(6):647-652. PubMed ID: 34124380
[TBL] [Abstract][Full Text] [Related]
13. Faecal calprotectin: current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists.
Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S
Intern Med J; 2016 May; 46(5):590-5. PubMed ID: 26946938
[TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
15. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
[TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
17. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
Mumolo MG; Bertani L; Ceccarelli L; Laino G; Di Fluri G; Albano E; Tapete G; Costa F
World J Gastroenterol; 2018 Sep; 24(33):3681-3694. PubMed ID: 30197475
[TBL] [Abstract][Full Text] [Related]
18. Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study.
Motaganahalli S; Beswick L; Con D; van Langenberg DR
Intern Med J; 2019 Jan; 49(1):94-100. PubMed ID: 29962008
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
